Price
$2.72
Increased by +2.64%
Dollar volume (20D)
39.86 K
ADR%
6.49
Earnings report date
Jun 21, 2024
Shares float
6.37 M
Shares short
1.14 K [0.02%]
Shares outstanding
9.40 M
Market cap
24.91 M
Beta
1.56
Price/earnings
N/A
20D range
2.63 3.11
50D range
2.63 3.50
200D range
1.72 3.59

Acasti Pharma Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.

The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage.

It also develops GTX-102, an oral mucosal spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia.

The company was incorporated in 2002 and is headquartered in Laval, Canada.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Feb 12, 24 -0.30
Decreased by -233.33%
-0.31
Increased by +3.23%
Nov 13, 23 -0.43
Decreased by -290.91%
-0.11
Decreased by -290.91%
Aug 11, 23 -0.54
Decreased by -440.00%
-0.09
Decreased by -500.00%
Jun 23, 23 -3.90
Decreased by -4.23 K%
-0.84
Decreased by -364.29%
Feb 14, 23 -0.09
Increased by +18.18%
-0.15
Increased by +40.00%
Nov 14, 22 -0.11
Decreased by -266.67%
-
Aug 11, 22 -0.10
Decreased by -25.00%
-
Jun 21, 22 -0.09
Increased by +62.50%
-0.13
Increased by +30.77%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Dec 31, 23 0.00
Decreased by N/A%
-2.39 M
Increased by +38.52%
Decreased by N/A%
Decreased by N/A%
Sep 30, 23 0.00
Decreased by N/A%
-3.72 M
Increased by +24.55%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by -100.00%
-4.02 M
Increased by +11.07%
Decreased by N/A%
Decreased by N/A%
Mar 31, 23 -32.00 K
Decreased by -346.15%
-29.09 M
Decreased by -623.56%
Increased by +90.90 K%
Increased by +393.95%
Dec 31, 22 0.00
Decreased by N/A%
-3.89 M
Decreased by -2.94%
Decreased by N/A%
Decreased by N/A%
Sep 30, 22 0.00
Decreased by N/A%
-4.93 M
Decreased by -602.45%
Decreased by N/A%
Decreased by N/A%
Jun 30, 22 32.00 K
Decreased by -72.17%
-4.52 M
Decreased by -45.09%
Decreased by -14.14 K%
Decreased by -421.43%
Mar 31, 22 13.00 K
Decreased by -88.70%
-4.02 M
Increased by +28.80%
Decreased by -30.92 K%
Decreased by -529.85%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY